Yeasen Biotechnology, established in 2014, stands at the forefront of the biotechnology industry, specializing in protein engineering and directed evolution technology. This innovative company is dedicated to advancing molecular enzymes and proteins to elevate research within the life sciences sector. Yeasen offers a comprehensive range of products, including PCR, NGS, reverse transcription, nucleic acid extraction and purification, as well as various services for cell culture, analysis, and transfection. Their robust product lineup is underpinned by state-of-the-art facilities, such as the Ultra Clean Molecular Enzyme factory, ensuring products consistently meet high-quality standards.

With a strong emphasis on research and development, Yeasen has established six core technology platforms, focusing on protein evolution, antibody specificity, and mRNA vaccine research. Their commitment to customer success is reflected in their collaborations with academic labs, therapeutic companies, and leading sequencing service providers. Yeasen aims to rank among the top global companies in life science tools, driving innovation to enhance health and quality of life.